Initial Patient Dosed in Phase 2a Clinical Trial Evaluating First-in-Class Human Milk-Based Therapy in Patients Undergoing Stem Cell Transplantation for Blood Cancers
https://reachmd.com/news/initial-patient-dosed-in-phase-2a-clinical-trial-evaluating-first-in-class-human-milk-based-therapy-in-patients-undergoing-stem-cell-transplantation-for-blood-cancers/2453134/
Seeking strategic partners for continued clinical development of PBCLN-010 with PBCLN-014, a lead investigational therapy comprising human milk sugars and gut bacteria found in nursing infants Recently published data demonstrated the human milk-based treatment can safely and predictably control gu…
Reprogamming Skin Cells to Act Like Stem Cells
https://reachmd.com/programs/clinicians-roundtable/reprogamming-skin-cells-to-act-like-stem-cells/2588/
Dr. Johnathan Moreno speaks with host Dr. Maurie Pickard about this year’s ground breaking research in the reprogramming of skin cells to act like stem cells. They also discuss the need for new embryonic cell lines that continue to be the gold standard. Continued progress in this area of research, h
Immune Cells Carry a Long-Lasting 'Memory' of Early-Life Pain
https://reachmd.com/news/immune-cells-carry-a-long-lasting-memory-of-early-life-pain/2462793/
Early-life injury can change how the body's pain response system develops at a genetic level, leading to a pain "memory" that can affect response to injuries occurring years later, according to a study in Cell Reports publishe…
Biology of Embryonic Stem Cells
https://reachmd.com/programs/clinicians-roundtable/biology-of-embryonic-stem-cells/2251/
John A. Kessler MD, Davee Professor of Stem Cell Biology, Chairman, Davee Department of Neurology, Northwestern University Medical School in Chicago. Dr. Kessler is one of the world’s leaders in stem cell research to repair central and peripheral nerve damage. He joins us to talk about the biology
The Stem Cell Research Debate
https://reachmd.com/programs/clinicians-roundtable/the-stem-cell-research-debate/967/
Dr. James Sherley, a stem cell heretic, discusses his stem cell views and proposes that many other researchers in his field share his strong views but do not always speak out because of their desire to get tenure and or be published. He also explains his side of the story regarding his tenure at MI
https://reachmd.com/programs/clinicians-roundtable/stem-cell-basics/964/
In this segment Dr. James Sherley offers physicians a review course on adult and embryonic stem cells.
Often Overlooked, a Common Infection During Pregnancy Kickstarts a Conversation About Newborn Screening
https://reachmd.com/news/often-overlooked-a-common-infection-during-pregnancy-kickstarts-a-conversation-about-newborn-screening/2451112/
On a spring day in the late 1980s, pediatrician Mark Schleiss was confronted with a difficult case: a months-old infant who had developed pneumonia. While many infants with pneumonia recover, this particular baby had grown so sick he was admitted to the ICU, where he died. The autopsy showed he h…
Beyond the Embryonic Stem Cell Debate
https://reachmd.com/programs/clinicians-roundtable/beyond-the-embryonic-stem-cell-debate/4314/
Although President Obama has favored funding for embryonic stem cell research, the moral debate continues. But that discussion may overshadow the fact that biotech companies have actually made the most early progress, not in embryonic stem cells, but in adult stem cells. Dr. Robert Harman, chief exe
Misconceptions of Embryonic Stem Cell Potential
https://reachmd.com/programs/clinicians-roundtable/misconceptions-of-embryonic-stem-cell-potential/965/
In this segment, Dr. James Sherley explains relationship between stem cells and human organs. He proposes that the future of embryonic stem cells are mis-represented and will not ever be able to deliver upon the many promises made.
Making Progress With Stem Cell Treatments
https://reachmd.com/programs/clinicians-roundtable/making-progress-with-stem-cell-treatments/2489/
A journal Nature report that scientists cloned an embryo of a monkey and harvested its stem cells have grabbed headlines, but just how much progress are we really making in stem cell treatments? Dr. Douglas Losordo, head of the program in Cardiovascular Medicine at Northwestern University tells the